Published in Cell iScience, this multi-pronged study combined ultra-large virtual screening with structural bioinformatics to identify potential therapeutic compounds targeting SARS-CoV-2 proteins. Innophore contributed the dynamic structural viral proteome analysis, identifying binding sites across 17 target proteins as part of a large international consortium effort.